Hyperbaric oxygen therapy for pyoderma gangrenosum. | Canada Hyperbarics Skip to main content
Clinical Study Australian and New Zealand journal of medicine 1984

Hyperbaric oxygen therapy for pyoderma gangrenosum.

Heng MC — Australian and New Zealand journal of medicine, 1984

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers developed and tested a simplified topical hyperbaric oxygen therapy technique on two patients with pyoderma gangrenosum.

What They Found

The topical hyperbaric oxygen therapy successfully treated both patients with pyoderma gangrenosum. It promoted abundant granulation tissue formation and halted further ulceration extension in these two cases.

What This Means for Canadian Patients

This topical hyperbaric oxygen therapy could offer a safer alternative to systemic administration for Canadian patients with pyoderma gangrenosum. If widely adopted, it may improve wound healing and prevent ulcer progression for those suffering from this challenging skin condition.

Canadian Relevance

This study has no direct Canadian connection.

Study Limitations

A significant limitation of this study is the very small sample size of only two patients.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Wound Care
Source Pubmed
PubMed ID 6597707
Year Published 1984
Journal Australian and New Zealand journal of medicine
MeSH Terms Aged; Humans; Hyperbaric Oxygenation; Leg Ulcer; Male; Middle Aged; Pyoderma

Cite This Study

Share

Find a Canadian Clinic Treating Wound Care

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.